Anbio Biotechnology (NNNN) Shares Outstanding (Weighted Average) (2023 - 2025)

Anbio Biotechnology has reported Shares Outstanding (Weighted Average) for 3 years, with the latest figure at $43.7 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 3.27% year-over-year to $43.7 million; the trailing twelve-month figure through Dec 2025 stood at $43.7 million (up 3.27% YoY), and the FY2025 full-year result was $43.7 million, up 3.27% from the prior year.
• Shares Outstanding (Weighted Average) for Q4 2025 stood at $43.7 million, up from $42.3 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $43.7 million in Q4 2025, with the low at $21.4 million in Q4 2023.
• Average Shares Outstanding (Weighted Average) over 3 years is $35.8 million, with a median of $42.3 million recorded in 2024.
• Year-over-year, Shares Outstanding (Weighted Average) soared 97.3% in 2024 and increased 3.27% in 2025.
• Tracing NNNN's Shares Outstanding (Weighted Average) over 3 years: stood at $21.4 million in 2023, then surged by 97.3% to $42.3 million in 2024, then increased by 3.27% to $43.7 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $43.7 million (Q4 2025), $42.3 million (Q4 2024), and $21.4 million (Q4 2023), per Business Quant data.

Peer Comparison